The technology is fascinating, but the hurdle has always been the 'milkshake' delivery system. In a city like New York, where rats have access to endless gourmet trash, what is the strategy for ensuring the rats choose the contraceptive bait over the pizza crust down the street? Palatability seems like the make-or-break factor for this biotech.
With J&J trading at a 52‑week high driven by strong momentum and positive sentiment, but analysts’ average price targets still clustered slightly below the current level, how do you balance momentum‑driven price action versus valuation and fundamental expectations ahead of the next earnings report, and what specific earnings metrics (e.g., guidance, margins, regional demand) will most likely determine whether the rally continues?
You argue that a reduction in U.S. dollar exposure can happen through price movement rather than actual capital flows — in your view, what specific market or policy conditions would most likely trigger the kind of valuation shift in USD assets that forces portfolio rebalancing without big transactional flows?
Latest Comments
Fed On Hold, Gold Flies, FX Reversals Build
This Biotech Is Selling Birth Control — For Rats
Johnson & Johnson At 52‑Week High: Momentum, Fundamentals And An Earnings Window
"Sell The Dollar": Think Price, Not Flows
Review After SenesTech On-Site Factory Tour
YouTube's Hottest Stocks Buzz: Top 10 Most Talked-About In January 2026
Trump Is “Probably Inclined To Keep Exxon Out” Of Venezuela
IDFC First Bank Share Price History With 52-Week High/Low Analysis
Is Quantum Entering Its Infrastructure Phase?
Starfighters Space Is Taking Off